TrialThe New England journal of medicine2015
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
James Larkin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4,079 papers cite itlatest 60 shown
this paperpooled ittrialcites it